A survey conducted by Nanyang Technological University, Singapore (NTU Singapore), involving 165 gastroenterologists and gastrointestinal surgeons in the APAC region, reveals that eight in ten say they accept and trust the use of AI-powered tools in diagnosing and assessing colorectal polyps, which are benign growths in the colon that could become cancerous.
Seven in 10 furthermore said they accept and trust using AI to guide an endoscopist on whether to remove polyps found in the bowel of those undergoing screening colonoscopy.
The study found that gastroenterologists with fewer than 10 years of clinical experience perceived a higher risk of AI-powered tools than their counterparts with more than 10 years of experience.
Matt is an award-winning storyteller, writer, and communicator currently based in Riyadh.
A native Englishman, his career has led him to diverse locations including China, Hong Kong, Iraq, Malaysia, Saudi Arabia, and the UAE.
In addition to founding HealthTechAsia, Matt is a co-founder of the non-profit Pul Alliance for Digital Health and Equity.
In a former life, he oversaw editorial coverage for Arab Health, Asia Health, Africa Health, and other key events.
In 2021, he won a Medical Travel Media Award, organised by Malaysia Healthcare Travel Council, and a Guardian Student Media Award in 2000.
Matt is an award-winning storyteller, writer, and communicator currently based in Riyadh.
A native Englishman, his career has led him to diverse locations including China, Hong Kong, Iraq, Malaysia, Saudi Arabia, and the UAE.
In addition to founding HealthTechAsia, Matt is a co-founder of the non-profit Pul Alliance for Digital Health and Equity.
In a former life, he oversaw editorial coverage for Arab Health, Asia Health, Africa Health, and other key events.
In 2021, he won a Medical Travel Media Award, organised by Malaysia Healthcare Travel Council, and a Guardian Student Media Award in 2000.
By Matthew Brady 
